Lysine methylation: Beyond histones

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 1, 2012, Pages 14-27

  Zhang, Xi ^a   Wen, Hong ^a   Shi, Xiaobing ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

epigenetics; lysine demethylase (KDM); lysine methyltransferase (KMT); methylation; p53

Indexed keywords

DOT1L PROTEIN, HUMAN; HISTONE DEMETHYLASE; HISTONE LYSINE METHYLTRANSFERASE; LYSINE; METHYLTRANSFERASE; PROTEIN METHYLTRANSFERASE; PROTEIN P53;

ACETYLATION; ANIMAL; HUMAN; METABOLISM; METHYLATION; MOUSE; PROTEIN PROCESSING; REVIEW;

ACETYLATION; ANIMALS; HISTONE DEMETHYLASES; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; LYSINE; METHYLATION; METHYLTRANSFERASES; MICE; PROTEIN METHYLTRANSFERASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84555208833     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr100     Document Type: Review

References (193)

1. Allis CD, Berger SL, Cote J, Dent S, Jenuwien T, Kouzarides T and Pillus L, et al. New nomenclature for chromatin-modifying enzymes. Cell 2007, 131: 633-636.
2. Qian C and Zhou MM. SET domain protein lysine methyltransferases: structure, specificity and catalysis. Cell Mol Life Sci 2006, 63: 2755-2763.
3. Aravind L, Abhiman S and Iyer LM. Natural history of the eukaryotic chromatin protein methylation system. Prog Mol Biol Transl Sci 2011, 101: 105-176.
4. Huang J, Dorsey J, Chuikov S, Perez-Burgos L, Zhang X, Jenuwein T and Reinberg D, et al. G9a and Glp methylate lysine 373 in the tumor suppressor p53. J Biol Chem 2010, 285: 9636-9641.
5. Pless O, Kowenz-Leutz E, Knoblich M, Lausen J, Beyermann M, Walsh MJ and Leutz A. G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-beta. J Biol Chem 2008, 283: 26357-26363.
6. Lee JS, Kim Y, Kim IS, Kim B, Choi HJ, Lee JM and Shin HJ, et al. Negative regulation of hypoxic responses via induced Reptin methylation. Mol Cell 2010, 39: 71-85.
7. Rathert P, Dhayalan A, Murakami M, Zhang X, Tamas R, Jurkowska R and Komatsu Y, et al. Protein lysine methyltransferase G9a acts on nonhistone targets. Nat Chem Biol 2008, 4: 344-346.
8. Chin HG, Esteve PO, Pradhan M, Benner J, Patnaik D, Carey MF and Pradhan S. Automethylation of G9a and its implication in wider substrate specificity and HP1 binding. Nucleic Acids Res 2007, 35: 7313-7323.
9. Huq MD, Ha SG and Wei LN. Modulation of retinoic acid receptor alpha activity by lysine methylation in the DNA binding domain. J Proteome Res 2008, 7: 4538-4545.
10. Van Duyne R, Easley R, Wu W, Berro R, Pedati C, Klase Z and Kehn-Hall K, et al. Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR. Retrovirology 2008, 5: 40.
11. Zhang K, Lin W, Latham JA, Riefler GM, Schumacher JM, Chan C and Tatchell K, et al. The Set1 methyltransferase opposes Ipl1 aurora kinase functions in chromosome segregation. Cell 2005, 122: 723-734.
12. Lu T, Jackson MW, Wang B, Yang M, Chance MR, Miyagi M and Gudkov AV, et al. Regulation of NF-kappaB by NSD1/FBXL11- dependent reversible lysine methylation of p65. Proc Natl Acad Sci USA 2010, 107: 46-51.
13. Huang J, Perez-Burgos L, Placek BJ, Sengupta R, Richter M, Dorsey JA and Kubicek S, et al. Repression of p53 activity by Smyd2-mediated methylation. Nature 2006, 444: 629-632.
14. Saddic LA, West LE, Aslanian A, Yates JR, III, Rubin SM, Gozani O and Sage J. Methylation of the retinoblastoma tumor suppressor by SMYD2. J Biol Chem 2010, 285: 37733-37740.
15. Kunizaki M, Hamamoto R, Silva FP, Yamaguchi K, Nagayasu T, Shibuya M and Nakamura Y, et al. The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3. Cancer Res 2007, 67: 10759-10765.
16. Shi X, Kachirskaia I, Yamaguchi H, West LE, Wen H, Wang EW and Dutta S, et al. Modulation of p53 function by SET8-mediated methylation at lysine 382. Mol Cell 2007, 27: 636-646.
17. Wang J, Hevi S, Kurash JK, Lei H, Gay F, Bajko J and Su H, et al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet 2009, 41: 125-129.
18. Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS and McKinney K, et al. Regulation of p53 activity through lysine methylation.Nature 2004, 432: 353-360.
19. Liu X, Wang D, Zhao Y, Tu B, Zheng Z, Wang L and Wang H, et al. Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1). Proc Natl Acad Sci USA 2011, 108: 1925-1930.
20. Kouskouti A, Scheer E, Staub A, Tora L and Talianidis I. Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol Cell 2004, 14: 175-182.
21. Munro S, Khaire N, Inche A, Carr S and La Thangue NB. Lysine methylation regulates the pRb tumour suppressor protein. Oncogene 2010, 29: 2357-2367.
22. Subramanian K, Jia D, Kapoor-Vazirani P, Powell DR, Collins RE, Sharma D and Peng J, et al. Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. Mol Cell 2008, 30: 336-347.
23. Esteve PO, Chin HG, Benner J, Feehery GR, Samaranayake M, Horwitz GA and Jacobsen SE, et al. Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells. Proc Natl Acad Sci USA 2009, 106: 5076-5081.
24. Yang J, Huang J, Dasgupta M, Sears N, Miyagi M, Wang B and Chance MR, et al. Reversible methylation of promoter-bound STAT3 by histonemodifying enzymes. Proc Natl Acad Sci USA 2010, 107: 21499-21504.
25. Yang XD, Huang B, Li M, Lamb A, Kelleher NL and Chen LF. Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J 2009, 28: 1055-1066.
26. Kontaki H and Talianidis I. Lysine methylation regulates E2F1-induced cell death. Mol Cell 2010, 39: 152-160.
27. Dhayalan A, Kudithipudi S, Rathert P and Jeltsch A. Specificity analysisbased identification of new methylation targets of the SET7/9 protein lysine methyltransferase. Chem Biol 2011, 18: 111-120.
28. Li Y, Reddy MA, Miao F, Shanmugam N, Yee JK, Hawkins D and Ren B, et al. Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 2008, 283: 26771-26781.
29. Pagans S, Kauder SE, Kaehlcke K, Sakane N, Schroeder S, Dormeyer W and Trievel RC, et al. The cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription. Cell Host Microbe 2010, 7: 234-244.
30. Ko S, Ahn J, Song CS, Kim S, Knapczyk-Stwora K and Chatterjee B. Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferase. Mol Endocrinol 2011, 25: 433-444.
31. Masatsugu T and Yamamoto K. Multiple lysine methylation of PCAF by Set9 methyltransferase. Biochem Biophys Res Commun 2009, 381: 22-26.
32. Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M and Opravil S, et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000, 406: 593-599.
33. Rice JC, Briggs SD, Ueberheide B, Barber CM, Shabanowitz J, Hunt DF and Shinkai Y, et al. Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell 2003, 12: 1591-1598.
34. Nielsen PR, Nietlispach D, Mott HR, Callaghan J, Bannister A, Kouzarides T and Murzin AG, et al. Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9. Nature 2002, 416: 103-107.
35. Fischle W, Wang Y, Jacobs SA, Kim Y, Allis CD and Khorasanizadeh S. Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by polycomb and HP1 chromodomains. Genes Dev 2003, 17: 1870-1881.
36. Collins RE, Northrop JP, Horton JR, Lee DY, Zhang X, Stallcup MR and Cheng X. The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules. Nat Struct Mol Biol 2008, 15: 245-250.
37. Tachibana M, Ueda J, Fukuda M, Takeda N, Ohta T, Iwanari H and Sakihama T, et al. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev 2005, 19: 815-826.
38. Falandry C, Fourel G, Galy V, Ristriani T, Horard B, Bensimon E and Salles G, et al. CLLD8/KMT1F is a lysine methyltransferase that is important for chromosome segregation. J Biol Chem 2010, 285: 20234-20241.
39. Wang H, An W, Cao R, Xia L, Erdjument-Bromage H, Chatton B and Tempst P, et al. mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression. Mol Cell 2003, 12: 475-487.
40. Clouaire T, de Las Heras JI, Merusi C and Stancheva I. Recruitment of MBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA. Nucleic Acids Res 2010, 38: 4620-4634.
41. Huyen Y, Zgheib O, Ditullio RA, Jr, Gorgoulis VG, Zacharatos P, Petty TJ and Sheston EA, et al. Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature 2004, 432: 406-411.
42. Krivtsov AV and Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 2007, 7: 823-833.
43. Dou Y, Milne TA, Ruthenburg AJ, Lee S, Lee JW, Verdine GL and Allis CD, et al. Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat Struct Mol Biol 2006, 13: 713-719.
44. Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I and Herr W, et al. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol 2004, 24: 5639-5649.
45. Hughes CM, Rozenblatt-Rosen O, Milne TA, Copeland TD, Levine SS, Lee JC and Hayes DN, et al. Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell 2004, 13: 587-597.
46. Lee MG, Villa R, Trojer P, Norman J, Yan KP, Reinberg D and Croce LD, et al. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 2007, 318: 447-450.
47. Keogh MC, Kurdistani SK, Morris SA, Ahn SH, Podolny V, Collins SR and Schuldiner M, et al. Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex. Cell 2005, 123: 593-605.
48. Carrozza MJ, Li B, Florens L, Suganuma T, Swanson SK, Lee KK and Shia WJ, et al. Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 2005, 123: 581-592.
49. Wang GG, Cai L, Pasillas MP and Kamps MP. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol 2007, 9: 804-812.
50. Rayasam GV, Wendling O, Angrand PO, Mark M, Niederreither K, Song L and Lerouge T, et al. NSD1 is essential for early post-implantation development and has a catalytically active SET domain. EMBO J 2003, 22: 3153-3163.
51. Schneider R, Bannister AJ and Kouzarides T. Unsafe SETs: histone lysine methyltransferases and cancer. Trends Biochem Sci 2002, 27: 396-402.
52. Nimura K, Ura K, Shiratori H, Ikawa M, Okabe M, Schwartz RJ and Kaneda Y. A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. Nature 2009, 460: 287-291.
53. Pei H, Zhang L, Luo K, Qin Y, Chesi M, Fei F and Bergsagel PL, et al. MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites. Nature 2011, 470: 124-128.
54. Zhou Z, Thomsen R, Kahns S and Nielsen AL. The NSD3L histone methyltransferase regulates cell cycle and cell invasion in breast cancer cells. Biochem Biophys Res Commun 2010, 398: 565-570.
55. Abu-Farha M, Lambert JP, Al-Madhoun AS, Elisma F, Skerjanc IS and Figeys D. The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase. Mol Cell Proteomics 2008, 7: 560-572.
56. Brown MA, Sims RJ, 3rd, Gottlieb PD and Tucker PW. Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex. Mol Cancer 2006, 5: 26.
57. Hamamoto R, Furukawa Y, Morita M, Iimura Y, Silva FP, Li M and Yagyu R, et al. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat Cell Biol 2004, 6: 731-740.
58. Gottlieb PD, Pierce SA, Sims RJ, Yamagishi H, Weihe EK, Harriss JV and Maika SD, et al. Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis. Nat Genet 2002, 31: 25-32.
59. Feng Q, Wang H, Ng HH, Erdjument-Bromage H, Tempst P, Struhl K and Zhang Y. Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain. Curr Biol 2002, 12: 1052-1058.
60. Nguyen AT and Zhang Y. The diverse functions of Dot1 and H3K79 methylation. Genes Dev 2011, 25: 1345-1358.
61. van Leeuwen F, Gafken PR and Gottschling DE. Dot1p modulates silencing in yeast by methylation of the nucleosome core. Cell 2002, 109: 745-756.
62. Shanower GA, Muller M, Blanton JL, Honti V, Gyurkovics H and Schedl P. Characterization of the grappa gene, the Drosophila histone H3 lysine 79 methyltransferase. Genetics 2005, 169: 173-184.
63. Jones B, Su H, Bhat A, Lei H, Bajko J, Hevi S and Baltus GA, et al. The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure. PLoS Genet 2008, 4: e1000190.
64. Okada Y, Feng Q, Lin Y, Jiang Q, Li Y, Coffield VM and Su L, et al. hDOT1L links histone methylation to leukemogenesis. Cell 2005, 121: 167-178.
65. Krivtsov AV, Feng Z, Lemieux ME, Faber J, Vempati S, Sinha AU and Xia X, et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell 2008, 14: 355-368.
66. Bernt KM, Zhu N, Sinha AU, Vempati S, Faber J, Krivtsov AV and Feng Z, et al. MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell 2011, 20: 66-78.
67. Daigle SR, Olhava EJ, Therkelsen CA, Majer CR, Sneeringer CJ, Song J and Johnston LD, et al. Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. Cancer Cell 2011, 20: 53-65.
68. Karachentsev D, Sarma K, Reinberg D and Steward R.PR-Set7-dependent methylation of histone H4 Lys 20 unctions in repression of gene expression and is essential for mitosis. Genes Dev 2005, 19: 431-435.
69. Nishioka K, Rice JC, Sarma K, Erdjument-Bromage H, Werner J, Wang Y and Chuikov S, et al. PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin. Mol Cell 2002, 9: 1201-1213.
70. Li Z, Nie F, Wang S and Li L. Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation. Proc Natl Acad Sci USA 2011, 108: 3116-3123.
71. Congdon LM, Houston SI, Veerappan CS, Spektor TM and Rice JC. PR-Set7-mediated monomethylation of histone H4 lysine 20 at specific genomic regions induces transcriptional repression. J Cell Biochem 2010, 110: 609-619.
72. Jorgensen S, Eskildsen M, Fugger K, Hansen L, Larsen MS, Kousholt AN and Syljuåsen RG, et al. SET8 is degraded via PCNA-coupled CRL4(CDT2) ubiquitylation in S phase and after UV irradiation. J Cell Biol 2011, 192: 43-54.
73. Centore RC, Havens CG, Manning AL, Li JM, Flynn RL, Tse A and Jin J, et al. CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase. Mol Cell 2010, 40: 22-33.
74. Abbas T, Shibata E, Park J, Jha S, Karnani N and Dutta A. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation. Mol Cell 2010, 40: 9-21.
75. Huen MS, Sy SM, van Deursen JM and Chen J. Direct interaction between SET8 and proliferating cell nuclear antigen couples 4-K20 methylation with DNA replication. J Biol Chem 2008, 283: 11073-11077.
76. Jorgensen S, Elvers I, Trelle MB, Menzel T, Eskildsen M, Jensen ON and Helleday T, et al. The histone methyltransferase SET8 is required for S-phase progression. J Cell Biol 2007, 179: 1337-1345.
77. Tardat M, Brustel J, Kirsh O, Lefevbre C, Callanan M, Sardet C and Julien E. The histone H4 Lys 20 methyltransferase PR-Set7 regulates replication origins in mammalian cells. Nat Cell Biol 2010, 12: 1086-1093.
78. Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, Reuter G and Reinberg D, et al. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev 2004, 18: 1251-1262.
79. Schotta G, Sengupta R, Kubicek S, Malin S, Kauer M, Callen E and Celeste A, et al. A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev 2008, 22: 2048-2061.
80. Greeson NT, Sengupta R, Arida AR, Jenuwein T and Sanders SL. Di-methyl H4 lysine 20 targets the checkpoint protein Crb2 to sites of DNA damage. J Biol Chem 2008, 283: 33168-33174.
81. Botuyan MV, Lee J, Ward IM, Kim JE, Thompson JR, Chen J and Mer G. Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell 2006, 127: 1361-1373.
82. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P and Jones RS, et al. Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science 2002, 298: 1039-1043.
83. Kuzmichev A, Nishioka K, Erdjument-Bromage H, Tempst P and Reinberg D. Histone methyltransferase activity associated with a human multiprotein complex containing the enhancer of Zeste protein. Genes Dev 2002, 16: 2893-2905.
84. Margueron R and Reinberg D. The polycomb complex PRC2 and its mark in life. Nature 2011, 469: 343-349.
85. Martin-Perez D, Piris MA and Sanchez-Beato M. olycomb proteins in hematologic malignancies. Blood 2010, 116: 5465-5475.
86. Ezhkova E, Pasolli HA, Parker JS, Stokes N, Su IH, Hannon G and Tarakhovsky A, et al. Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell 2009, 136: 1122-1135.
87. Wei Y, Chen YH, Li LY, Lang J, Yeh SP, Shi B and Yang CC, et al. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat Cell Biol 2011, 13: 87-94.
88. Kaneko S, Li G, Son J, Xu CF, Margueron R, Neubert TA and Reinberg D. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev 2010, 24: 2615-2620.
89. Chen S, Bohrer LR, Rai AN, Pan Y, Gan L, Zhou X and Bagchi A, et al. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat Cell Biol 2010, 12: 1108-1114.
90. Ezhkova E, Lien WH, Stokes N, Pasolli HA, Silva JM and Fuchs E. EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair. Genes Dev 2011, 25: 485-498.
91. Shen X, Liu Y, Hsu YJ, Fujiwara Y, Kim J, Mao X and Yuan GC, et al. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol Cell 2008, 32: 491-502.
92. Nishioka K, Chuikov S, Sarma K, Erdjument-Bromage H, Allis CD, Tempst P and Reinberg D. Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev 2002, 16: 479-489.
93. Pradhan S, Chin HG, Esteve PO and Jacobsen SE. SET7/9 mediated methylation of non-histone proteins in mammalian cells. Epigenetics 2009, 4: 383-387.
94. Couture JF, Collazo E, Hauk G and Trievel RC. Structural basis for the methylation site specificity of SET7/9. Nat Struct Mol Biol 2006, 13: 140-146.
95. Abbondanza C, Medici N, Nigro V, Rossi V, Gallo L, Piluso G and Belsito A, et al. The retinoblastoma-interacting zinc-finger protein RIZ is a downstream effector of estrogen action. Proc Natl Acad Sci USA 2000, 97: 3130-3135.
96. Huang S. Histone methyltransferases, diet nutrients and tumour suppressors. Nat Rev Cancer 2002, 2: 469-476.
97. Kim KC, Geng L and Huang S. Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res 2003, 63: 7619-7623.
98. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA and Casero RA, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004, 119: 941-953.
99. Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P and Zhang Y. Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006, 439: 811-816.
100. Shi Y and Whetstine JR. Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 2007, 25: 1-14.
101. Cloos PA, Christensen J, Agger K and Helin K. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev 2008, 22: 1115-1140.
102. Klose RJ and Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 2007, 8: 307-318.
103. Huang J, Sengupta R, Espejo AB, Lee MG, Dorsey JA, Richter M and Opravil S, et al. p53 is regulated by the lysine demethylase LSD1. Nature 2007, 449: 105-108.
104. Cho HS, Suzuki T, Dohmae N, Hayami S, Unoki M, Yoshimatsu M and Toyokawa G, et al. Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells. Cancer Res 2011, 71: 655-660.
105. Lee MG, Wynder C, Cooch N and Shiekhattar R. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 2005, 437: 432-435.
106. Yang M, Gocke CB, Luo X, Borek D, Tomchick DR, Machius M and Otwinowski Z, et al. Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase. Mol Cell 2006, 23: 377-387.
107. Metzger E, Wissmann M, Yin N, Muller JM, Schneider R, Peters AH and Günther T, et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005, 437: 436-439.
108. Wissmann M, Yin N, Muller JM, Greschik H, Fodor BD, Jenuwein T and Vogler C, et al. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat Cell Biol 2007, 9: 347-353.
109. Hu Q, Kwon YS, Nunez E, Cardamone MD, Hutt KR, Ohgi KA and Garcia-Bassets I, et al. Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc Natl Acad Sci USA 2008, 105: 19199-19204.
110. Nicholson TB and Chen T. LSD1 demethylates histone and non-histone proteins. Epigenetics 2009, 4: 129-132.
111. Yang Z, Jiang J, Stewart DM, Qi S, Yamane K, Li J and Zhang Y, et al. AOF1 is a histone H3K4 demethylase possessing demethylase activity-independent repression function. Cell Res 2010, 20: 276-287.
112. Ciccone DN, Su H, Hevi S, Gay F, Lei H, Bajko J and Xu G, et al. KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature 2009, 461: 415-418.
113. Karytinos A, Forneris F, Profumo A, Ciossani G, Battaglioli E, Binda C and Mattevi A. A novel mammalian flavin-dependent histone demethylase. J Biol Chem 2009, 284: 17775-17782.
114. Fang R, Barbera AJ, Xu Y, Rutenberg M, Leonor T, Bi Q and Lan F, et al. Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation. Mol Cell 2011, 39: 222-233.
115. van Essen D, Zhu Y and Saccani S. A feed-forward circuit controlling inducible NF-kappaB target gene activation by promoter histone demethylation. Mol Cell 2011, 39: 750-760.
116. Frescas D, Guardavaccaro D, Bassermann F, Koyama-Nasu R and Pagano M. JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes. Nature 2007, 450: 309-313.
117. He J, Kallin EM, Tsukada Y and Zhang Y. The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15(Ink4b). Nat Struct Mol Biol 2008, 15: 1169-1175.
118. Koyama-Nasu R, David G and Tanese N. The F-box protein Fbl10 is a novel transcriptional repressor of c-Jun. Nat Cell Biol 2007, 9: 1074-1080.
119. Tanaka Y, Okamoto K, Teye K, Umata T, Yamagiwa N, Suto Y and Zhang Y, et al. JmjC enzyme KDM2A is a regulator of rRNA transcription in response to starvation. EMBO J 2010, 29: 1510-1522.
120. Sanchez C, Sanchez I, Demmers JA, Rodriguez P, Strouboulis J and Vidal M. Proteomics analysis of Ring1B/Rnf2 interactors identifies a novel complex with the Fbxl10/Jhdm1B histone demethylase and the Bcl6 interacting corepressor. Mol Cell Proteomics 2007, 6: 820-834.
121. Yamane K, Toumazou C, Tsukada Y, Erdjument-Bromage H, Tempst P, Wong J and Zhang Y. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 2006, 125: 483-495.
122. Okada Y, Scott G, Ray MK, Mishina Y and Zhang Y. Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis. Nature 2007, 450: 119-123.
123. Krieg AJ, Rankin EB, Chan D, Razorenova O, Fernandez S and Giaccia AJ. Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth. Mol Cell Biol 2009, 30: 344-353.
124. Tateishi K, Okada Y, Kallin EM and Zhang Y. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 2009, 458: 757-761.
125. Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z and Spooner E, et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 2006, 125: 467-481.
126. Klose RJ, Yamane K, Bae Y, Zhang D, Erdjument-Bromage H, Tempst P and Wong J, et al. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature 2006, 442: 312-316.
127. Fodor BD, Kubicek S, Yonezawa M, O'Sullivan RJ, Sengupta R, Perez-Burgos L and Opravil S, et al. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev 2006, 20: 1557-1562.
128. Huang Y, Fang J, Bedford MT, Zhang Y and Xu RM. Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A. Science 2006, 312: 748-751.
129. Adams-Cioaba MA and Min J. Structure and function of histone methylation binding proteins. Biochem Cell Biol 2009, 87: 93-105.
130. Shin S and Janknecht R. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Biochem Biophys Res Commun 2007, 359: 742-746.
131. Kawazu M, Saso K, Tong KI, McQuire T, Goto K, Son DO and Wakeham A, et al. Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLoS One 2011, 6: e17830.
132. Shi L, Sun L, Li Q, Liang J, Yu W, Yi X and Yang X, et al. Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc Natl Acad Sci USA 2011, 108: 7541-7546.
133. Ponnaluri VK, Vavilala DT, Putty S, Gutheil WG and Mukherji M. Identification of non-histone substrates for JMJD2A-C histone demethylases. Biochem Biophys Res Commun 2009, 390: 280-284.
134. Ponnaluri VK, Vavilala DT and Mukherji M. Studies on substrate specificity of Jmjd2a-c histone demethylases. Biochem Biophys Res Commun 2011, 405: 588-592.
135. Xiang Y, Zhu Z, Han G, Ye X, Xu B, Peng Z and Ma Y, et al. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc Natl Acad Sci USA 2007, 104: 19226-19231.
136. Christensen J, Agger K, Cloos PA, Pasini D, Rose S, Sennels L and Rappsilber J, et al. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell 2007, 128: 1063-1076.
137. Iwase S, Lan F, Bayliss P, de la Torre-Ubieta L, Huarte M, Qi HH and Whetstine JR, et al. The X-linked mental retardation gene SMCX/ JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 2007, 128: 1077-1088.
138. Klose RJ, Yan Q, Tothova Z, Yamane K, Erdjument-Bromage H, Tempst P and Gilliland DG, et al. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 2007, 128: 889-900.
139. Yamane K, Tateishi K, Klose RJ, Fang J, Fabrizio LA, Erdjument-Bromage H and Taylor-Papadimitriou J, et al. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell 2007, 25: 801-812.
140. Tahiliani M, Mei P, Fang R, Leonor T, Rutenberg M, Shimizu F and Li J, et al. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 2007, 447: 601-605.
141. Lee MG, Norman J, Shilatifard A and Shiekhattar R. Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein. Cell 2007, 128: 877-887.
142. Wang GG, Song J, Wang Z, Dormann HL, Casadio F, Li H and Luo JL, et al. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 2009, 459: 847-851.
143. Blair LP, Cao J, Zou MR, Sayegh J and Yan Q. Epigenetic regulation by lysine demethylase 5 (KDM5) enzymes in cancer. Cancers (Basel) 2011, 3: 1383-1404.
144. De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G and Natoli G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 2007, 130: 1083-1094.
145. Hong S, Cho YW, Yu LR, Yu H, Veenstra TD and Ge K. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc Natl Acad Sci USA 2007, 104: 18439-18444.
146. Xiang Y, Zhu Z, Han G, Lin H, Xu L and Chen CD. JMJD3 is a histone H3K27 demethylase. Cell Res 2007, 17: 850-857.
147. Agger K, Cloos PA, Christensen J, Pasini D, Rose S, Rappsilber J and Issaeva I, et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 2007, 449: 731-734.
148. Lan F, Bayliss PE, Rinn JL, Whetstine JR, Wang JK, Chen S and Iwase S, et al. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 2007, 449: 689-694.
149. Wang JK, Tsai MC, Poulin G, Adler AS, Chen S, Liu H and Shi Y, et al. The histone demethylase UTX enables RB-dependent cell fate control. Genes Dev 2010, 24: 327-332.
150. McLaughlin-Drubin ME, Crum CP and Munger K. Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc Natl Acad Sci USA 2011, 108: 2130-2135.
151. Wen H, Li J, Song T, Lu M, Kan PY, Lee MG and Sha B, et al. Recognition of histone H3K4 trimethylation by the plant homeodomain of PHF2 modulates histone demethylation. J Biol Chem 2010, 285: 9322-9326.
152. Feng W, Yonezawa M, Ye J, Jenuwein T and Grummt I. PHF8 activates transcription of rRNA genes through H3K4me3 binding and H3K9me1/2 demethylation. Nat Struct Mol Biol 2010, 17: 445-450.
153. Fortschegger K, de Graaf P, Outchkourov NS, van Schaik FM, Timmers HT and Shiekhattar R. PHF8 targets histone methylation and RNA polymerase II to activate transcription. Mol Cell Biol 2010, 30: 3286-3298.
154. Qiu J, Shi G, Jia Y, Li J, Wu M, Li J and Dong S, et al. The X-linked mental retardation gene PHF8 is a histone demethylase involved in neuronal differentiation. Cell Res 2010, 20: 908-918.
155. Zhu Z, Wang Y, Li X, Wang Y, Xu L, Wang X and Sun T, et al. PHF8 is a histone H3K9me2 demethylase regulating rRNA synthesis. Cell Res 2010, 20: 794-801.
156. Kleine-Kohlbrecher D, Christensen J, Vandamme J, Abarrategui I, Bak M, Tommerup N and Shi X, et al. A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation. Mol Cell 2010, 38: 165-178.
157. Baba A, Ohtake F, Okuno Y, Yokota K, Okada M, Imai Y and Ni M, et al. PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B. Nat Cell Biol 2011, 13: 669-676.
158. Liu W, Tanasa B, Tyurina OV, Zhou TY, Gassmann R, Liu WT and Ohgi KA, et al. PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression. Nature 2010, 466: 508-512.
159. Qi HH, Sarkissian M, Hu GQ, Wang Z, Bhattacharjee A, Gordon DB and Gonzales M, et al. Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development. Nature 2010, 466: 503-507.
160. Yu L, Wang Y, Huang S, Wang J, Deng Z, Zhang Q and Wu W, et al. Structural insights into a novel histone demethylase PHF8. Cell Res 2010, 20: 166-173.
161. Horton JR, Upadhyay AK, Qi HH, Zhang X, Shi Y and Cheng X. Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases. Nat Struct Mol Biol 2010, 17: 38-43.
162. Chen L, Li Z, Zwolinska AK, Smith MA, Cross B, oomen J and Yuan ZM, et al. MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output. EMBO J 2010, 29: 2538-2552.
163. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997, 88: 323-331.
164. Kruse JP and Gu W. Modes of p53 regulation. Cell 2009, 137: 609-622.
165. Lee JS, Smith E and Shilatifard A. The language of histone crosstalk. Cell 2010, 142: 682-685.
166. Latham JA and Dent SY. Cross-regulation of histone modifications. Nat Struct Mol Biol 2007, 14: 1017-1024.
167. Ivanov GS, Ivanova T, Kurash J, Ivanov A, Chuikov S, Gizatullin F and Herrera-Medina EM, et al. Methylation-acetylation interplay activates p53 in response to DNA damage. Mol Cell Biol 2007, 27: 6756-6769.
168. Kurash JK, Lei H, Shen Q, Marston WL, Granda BW, Fan H and Wall D, et al. Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo. Mol Cell 2008, 29: 392-400.
169. Xu S, Zhong C, Zhang T and Ding J. Structure of human lysine methyltransferase Smyd2 reveals insights into the substrate divergence in Smyd proteins. J Mol Cell Biol 2011, 3: 293-300.
170. Martin C and Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 2005, 6: 838-849.
171. West LE, Roy S, Lachmi-Weiner K, Hayashi R, Shi X, Appella E and Kutateladze TG, et al. The MBT repeats of L3MBTL1 link SET8-mediated p53 methylation at lysine 382 to target gene repression. J Biol Chem 2010, 285: 37725-37732.
172. Kachirskaia I, Shi X, Yamaguchi H, Tanoue K, Wen H, Wang EW and Appella E, et al. Role for 53BP1 Tudor domain recognition of p53 dimethylated at lysine 382 in DNA damage signaling. J Biol Chem 2008, 283: 34660-34666.
173. Roy S, Musselman CA, Kachirskaia I, Hayashi R, Glass KC, Nix JC and Gozani O, et al. Structural insight into p53 recognition by the 53BP1 tandem Tudor domain. J Mol Biol 2010, 398: 489-496.
174. Lehnertz B, Rogalski JC, Schulze FM, Yi L, Lin S, Kast J and Rossi FMV. p53-dependent transcription and tumor suppression are not affected in Set7/9-deficient mice. Mol Cell 2011, 43: 673-680.
175. Campaner S, Spreafico F, Burgold T, Doni M, Rosato U, Amati B and Testa G. The methyltransferase set7/9 (Setd7) is dispensable for the p53-mediated DNA damage response in vivo. Mol Cell 2011, 43: 681-688.
176. Feng L, Lin T, Uranishi H, Gu W and Xu Y. Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol Cell Biol 2005, 25: 5389-5395.
177. Krummel KA, Lee CJ, Toledo F and Wahl GM. The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation. Proc Natl Acad Sci USA 2005, 102: 10188-10193.
178. Wang H, Cao R, Xia L, Erdjument-Bromage H, Borchers C, Tempst P and Zhang Y. Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell 2001, 8: 1207-1217.
179. Carr SM, Munro S, Kessler B, Oppermann U and La Thangue NB. Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein. EMBO J 2011, 30: 317-327.
180. Ea CK and Baltimore D. Regulation of NF-kappaB activity through lysine monomethylation of p65. Proc Natl Acad Sci USA 2009, 106: 18972-18977.
181. Levy D, Kuo AJ, Chang Y, Schaefer U, Kitson C, Cheung P and Espejo A, et al. Lysine methylation of the NF-kappaB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-kappaB signaling. Nat Immunol 2011, 12: 29-36.
182. Sampath SC, Marazzi I, Yap KL, Sampath SC, Krutchinsky AN, Mecklenbrauker I and Viale A, et al. Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly. Mol Cell 2007, 27: 596-608.
183. Webb KJ, Laganowsky A, Whitelegge JP and Clarke SG. Identification of two SET domain proteins required for methylation of lysine residues in yeast ribosomal protein Rpl42ab. J Biol Chem 2008, 283: 35561-35568.
184. Porras-Yakushi TR, Whitelegge JP, Miranda TB and Clarke S. A novel SET domain methyltransferase modifies ribosomal protein Rpl23ab in yeast. J Biol Chem 2005, 280: 34590-34598.
185. Ying Z, Mulligan RM, Janney N and Houtz RL. Rubisco small and large subunit N-methyltransferases. Bi- and mono-functional methyltransferases that methylate the small and large subunits of Rubisco. J Biol Chem 1999, 274: 36750-36756.
186. Rathert P, Dhayalan A, Ma H and Jeltsch A. Specificity of protein lysine methyltransferases and methods for detection of lysine methylation of non-histone proteins. Mol Biosyst 2008, 4: 1186-1190.
187. Mok J, Kim PM, Lam HY, Piccirillo S, Zhou X, Jeschke GR and Sheridan DL, et al. Deciphering protein kinase specificity through large-scale analysis of yeast phosphorylation site motifs. Sci Signal 2010, 3: ra12.
188. Ong SE and Mann M. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protoc 2006, 1: 2650-2660.
189. Oppermann FS, Gnad F, Olsen JV, Hornberger R, Greff Z, Keri G and Mann M, et al. Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics 2009, 8: 1751-1764.
190. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P and Mann M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127: 635-648.
191. Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T and Yao J, et al. Regulation of cellular metabolism by protein lysine acetylation. Science 2010, 327: 1000-1004.
192. Hsia DA, Tepper CG, Pochampalli MR, Hsia EY, Izumiya C, Huerta SB and Wright ME, et al. KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation. Proc Natl Acad Sci USA 2010, 107: 9671-9676.
193. Jones MA, Covington MF, DiTacchio L, Vollmers C, Panda S and Harmer SL. Jumonji domain protein JMJD5 functions in both the plant and human circadian systems. Proc Natl Acad Sci USA 2010, 107: 21623-21628.